Related references
Note: Only part of the references are listed.Induction of Psychosis by Δ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?
Daniel Kleinloog et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Cannabinoids attenuate hippocampal gamma oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells
Noemi Holderith et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
Paul D. Morrison et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
Toby T. Winton-Brown et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Christian D. Schubart et al.
SCHIZOPHRENIA RESEARCH (2011)
Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivoΔ9-THC exposure-impaired hippocampal synaptic plasticity
Ni Fan et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Central nervous system effects of haloperidol on THC in healthy male volunteers
Marieke Liem-Moolenaar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Inequalities in healthcare provision for people with severe mental illness
David Lawrence et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
Rebecca Kuepper et al.
SCHIZOPHRENIA RESEARCH (2010)
High-potency cannabis and the risk of psychosis
Marta Di Forti et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Cannabis and psychosis/schizophrenia: human studies
Deepak Cyril D'Souza et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Alteration of Theta Timescale Dynamics of Hippocampal Place Cells by a Cannabinoid Is Associated with Memory Impairment
David Robbe et al.
JOURNAL OF NEUROSCIENCE (2009)
Can recreational doses of THC produce significant dopamine release in the human striatum?
Paul R. A. Stokes et al.
NEUROIMAGE (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Matthijs G. Bossong et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
P. D. Morrison et al.
PSYCHOLOGICAL MEDICINE (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cannabinoids and psychosis
R. Andrew Sewell et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample
E. Barkus et al.
PSYCHOLOGICAL MEDICINE (2008)
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans
Deepak Cyril D'Souza et al.
PSYCHOPHARMACOLOGY (2008)
Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS)
C. E. L. Green et al.
PSYCHOLOGICAL MEDICINE (2008)
Science and society - Cannabis, the mind and society: the hash realities
Robin M. Murray et al.
NATURE REVIEWS NEUROSCIENCE (2007)
A measure of state persecutory ideation for experimental studies
Daniel Freeman et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2007)
Cannabinoids reveal importance of spike timing coordination in hippocampal function
David Robbe et al.
NATURE NEUROSCIENCE (2006)
The acute effects of cannabinoids on memory in humans: a review
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2006)
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans
M Naef et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
(-)-cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens
RG Pertwee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Different effects of nabilone and cannabidiol on binocular depth inversion in man
FM Leweke et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
N Hajos et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
